The estimated Net Worth of George M Lasezkay is at least $1.92 Million dollars as of 18 January 2024. George Lasezkay owns over 18,000 units of Clearside Biomedical Inc stock worth over $611,216 and over the last 7 years he sold CLSD stock worth over $248,472. In addition, he makes $1,059,190 as President, Chief Executive Officer, and Director at Clearside Biomedical Inc.
Sign up
George Lasezkay CLSD stock SEC Form 4 insiders trading
George has made over 12 trades of the Clearside Biomedical Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 18,000 units of CLSD stock worth $22,860 on 18 January 2024.
The largest trade he's ever made was selling 32,150 units of Clearside Biomedical Inc stock on 12 May 2020 worth over $63,979. On average, George trades about 5,974 units every 70 days since 2017. As of 18 January 2024 he still owns at least 466,577 units of Clearside Biomedical Inc stock.
You can see the complete history of George Lasezkay stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
George Lasezkay biography
Dr. George Lasezkay Pharm.D. J.D. serves as President, Chief Executive Officer, Director of the Company. Dr. Lasezkay has served as a director of our company since August 2017 and our President and Chief Executive Officer since March 2020. He previously served as our Interim Chief Executive Officer from April 2019 to March 2020. Dr. Lasezkay served as Executive Vice President and General Counsel of Acucela Inc., a pharmaceutical company, from August 2015 to July 2016. From 2005 to December 2015, he was President of HorizonPharma Group, a consulting practice. From 2013 to January 2017, he was an adjunct professor in pharmaceutical law and policy at the University of San Diego School of Law. From 1989 to 2002, Dr. Lasezkay served in various roles of increasing responsibility at Allergan, Inc. a global pharmaceutical and medical aesthetics company, culminating as the Corporate Vice President for Corporate Development. Dr. Lasezkay received his B.S. and Pharm.D. degrees from the University of Buffalo, a J.D. degree from the University of Southern California Gould School of Law and a Certificate, Dispute Resolution from Pepperdine University School of Law. Our board of directors believes that Dr. Lasezkay’s role as our President and Chief Executive Officer and his diverse experience working with a number of emerging biopharmaceutical companies provides him with the qualifications and skills to serve as a director of our company.
What is the salary of George Lasezkay?
As the President, Chief Executive Officer, and Director of Clearside Biomedical Inc, the total compensation of George Lasezkay at Clearside Biomedical Inc is $1,059,190. There are no executives at Clearside Biomedical Inc getting paid more.
How old is George Lasezkay?
George Lasezkay is 68, he's been the President, Chief Executive Officer, and Director of Clearside Biomedical Inc since 2020. There are 3 older and 10 younger executives at Clearside Biomedical Inc. The oldest executive at Clearside Biomedical Inc is Nancy Hutson, 70, who is the Independent Director.
What's George Lasezkay's mailing address?
George's mailing address filed with the SEC is C/O CLEARSIDE BIOMEDICAL, INC., 900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GA, 30005.
Insiders trading at Clearside Biomedical Inc
Over the last 8 years, insiders at Clearside Biomedical Inc have traded over $11,999,807 worth of Clearside Biomedical Inc stock and bought 4,477,928 units worth $22,264,136 . The most active insiders traders include Bradford T Whitmore, Clay Thorp, and Venture Advisors Iv Sbic, L.... On average, Clearside Biomedical Inc executives and independent directors trade stock every 30 days with the average trade being worth of $82,593. The most recent stock trade was executed by Ngai Hang Victor Chong on 24 June 2024, trading 23,500 units of CLSD stock currently worth $24,910.
What does Clearside Biomedical Inc do?
clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.
What does Clearside Biomedical Inc's logo look like?
Complete history of George Lasezkay stock trades at Clearside Biomedical Inc
Clearside Biomedical Inc executives and stock owners
Clearside Biomedical Inc executives and other stock owners filed with the SEC include:
-
George Lasezkay,
President, Chief Executive Officer, Director -
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.,
Pres, CEO & Director -
Dr. George M. Lasezkay Pharm.D., Pharma.D., J.D.,
Pres, CEO & Director -
Charles Deignan,
Chief Financial Officer -
Dr. Thomas A. Ciulla M.B.A., M.D.,
Chief Medical Officer & Chief Devel. Officer -
Charles A. Deignan,
Chief Financial Officer -
Jenny Kobin,
IR Contact Officer -
Clay Thorp,
Independent Director -
Nancy Hutson,
Independent Director -
William Humphries,
Independent Director -
Jeffrey Edwards,
Independent Director -
Richard Croarkin,
Independent Director -
Christy Shaffer,
Independent Chairman of the Board -
Susan L. Coultas Ph.D.,
Chief Clinical Officer -
Rick McElheny,
VP of Corp. Devel. -
Leslie B. Zacks,
Gen. Counsel, Chief Compliance Officer & Sec. -
Jenny R. Kobin,
Head of Investor Relations -
Venture Advisors Iii, Llc H...,
-
Venture Advisors Iv Sbic, L...,
-
Venture Advisors Iii, Llc H...,
-
Evgeny Zaytsev,
Director -
Daniel H. White,
President and CEO -
Investments S.A.R.L.Rusnano...,
-
Derek Yoon,
Director -
Gerald D. Cagle,
Director -
Venture Advisors Iv Sbic, L...,
-
Glenn Noronha,
Executive Vice President, R&D -
Thomas Ciulla,
Chief Medical Officer -
Brion S. Raymond,
Chief Commercial Officer -
Anthony S Gibney,
-
Bradford T Whitmore,
10% owner -
Ngai Hang Victor Chong,
Chief Medical Officer -
Benjamin R Yerxa,